Bhavesh Kotak
Bhavesh Kotak publishes mostly in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Dermatology, on topics such as Advancements in Transdermal Drug Delivery, Antiplatelet Therapy and Cardiovascular Diseases and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #6,272,127 of 7,710,434 ranked researchers
- Rank in India
- #200,720 of 280,097
- Works
- 36
- Citations
- 188
- Citations per work
- 5.2
What does Bhavesh Kotak research?
Bhavesh Kotak's work is mostly in Medicine (40%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2054.6%
- Health Sciences1439.7%
- Medicine1439.7%
- Life Sciences25.7%
- 1Cardiology and Cardiovascular Medicine17% of their works
- 2Endocrinology, Diabetes and Metabolism9% of their works
- 3Dermatology6% of their works
- 4Pharmaceutical Science6% of their works
- 5Pulmonary and Respiratory Medicine4% of their works
- 6Public Health, Environmental and Occupational Health3% of their works
Research topics
- Advancements in Transdermal Drug Delivery
- Antiplatelet Therapy and Cardiovascular Diseases
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Antibiotic Resistance in Bacteria
- Acute Myocardial Infarction Research
- Pneumonia and Respiratory Infections
- Antibiotic Use and Resistance
- Pediatric health and respiratory diseases
Which keywords describe Bhavesh Kotak's research?
The keywords of their largest research topics: Cardiovascular Disease, Antibiotic Resistance, Epidemiology, Aspirin, Clopidogrel, Diabetes, Metabolic Syndrome and Microneedles.
- Global Health
- Antimicrobial Stewardship
- Myocardial Infarction
- ESKAPE Pathogens
- Acute Coronary Syndromes
- Microneedles
- Diabetes
- Aspirin
- Antibiotic Resistance
- Cardiovascular Disease
- Epidemiology
- Clopidogrel
- Metabolic Syndrome
- Solid Lipid Nanoparticles
- Community-Acquired Pneumonia
- Multidrug-Resistant Bacteria
- Pneumococcal Conjugate Vaccine
- Child Care
- Infection Control Measures
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cardiovascular Disease72 topics
- Antibiotic Resistance52 topics
- Epidemiology52 topics
- Aspirin41 topic
- Clopidogrel41 topic
- Diabetes41 topic
- Metabolic Syndrome41 topic
- Microneedles41 topic
- Solid Lipid Nanoparticles41 topic
- Acute Coronary Syndromes31 topic
- Community-Acquired Pneumonia31 topic
- ESKAPE Pathogens31 topic
- Multidrug-Resistant Bacteria31 topic
- Myocardial Infarction31 topic
- Pneumococcal Conjugate Vaccine31 topic
- Antimicrobial Stewardship21 topic
- Child Care21 topic
- Global Health21 topic
- Infection Control Measures21 topic
Where does Bhavesh Kotak work?
Bhavesh Kotak's main affiliation in the publication record is Dr. Reddy's Laboratories (India), India.
How many publications and citations does Bhavesh Kotak have?
OpenAlex counts 36 works and 188 citations for Bhavesh Kotak, an h-index of 6, ranking #6,272,127 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Bhavesh Kotak
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Bhavesh Kotak. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.